[removed]Seegene[/removed], Rockville, Md, today announced that the molecular diagnostic branch of the Ministry of Health and Long-Term Care for Ontario, Canada, has reported that the Seeplex respiratory diagnostic test was successfully used to detect respiratory virus and pneumobacters in recent public screenings.
The Seeplex is the only respiratory diagnostic test that can simultaneously detect 11 different respiratory RNA viruses, 2 DNA viruses, and 5 pneumonia bacteria from samples including nasopharyngeal aspirates, nasopharyngeal swabs and bronchoalveolar lavage. As the test can be performed for the price of testing for a single pathogen Seeplex changes the current economics of rapid diagnostic testing. This monetary advantage may allow for more public screenings, similar to the one in Ontario.
"Antimicrobial drug resistance is a major public health concern and a threat to the effectiveness of existing antimicrobial drugs. Seegene’s multi-pathogen Seeplex tests give clinical healthcare personnel the ability to quickly determine whether a patient’s respiratory ailment is caused by a virus or bacteria, and subsequently prescribe the best course of treatment whether an antibiotic, antimicrobial or bed rest," says Jong-Yoon Chun, founder and chief dxecutive officer, Seegene.
